About this event
- Date and time Tue 20 Sep 2022 from 8:00am to 6:00pm
- Location Royal Society of Medicine
- Organised by Rheumatology and Rehabilitation
By looking back at the work of Professor David Isenberg, attendees will receive a detailed review of advances in our understanding of autoimmune rheumatic diseases (ARDs).
We will explore the pathogenesis, clinical features, treatment and outcomes of ARDs including lupus, myositis, Sjögren’s syndrome and rheumatoid arthritis. Our speakers will ensure that attendees are provided with the most up-to-date understanding of ARDs and their therapy options.
Attend this event to:
- Understand the most effective methods for assessing ARDs
- Gain a better understanding of the current knowledge of immunopathology
- Explore key advances in therapy options
We are also offering this event as a live stream for people who cannot attend in-person. Please click here to book.
Follow us on:
Agenda
View the programme
Registration, tea and coffee
Welcome and introduction
Professor David Isenberg, Arthritis Research Diamond Jubilee Professor of Rheumatology, University College London
A few words on behalf of the University College London Medical School
Professor Derek Gilroy, Acting Head, Division of Medicine, University College London
A few words on behalf of University College London Hospitals NHS Foundation Trust
Dr Debajit Sen, Consultant Paediatric, Adolescent and Adult Rheumatologist, University College London Hospitals NHS Foundation Trust and Honorary Clinical Professor, Division of Medicine, University College London
Session 1
Chairs: Professor Peter Lydyard, Emeritus Professor of Immunology, University College London and Dr Debajit Sen
Long term outcomes in the University College London Hospitals lupus cohort
Professor Anisur Rahman, Professor of Rheumatology, University College London Hospitals NHS Foundation Trust
It started with myositis...
Professor Geraldine Cambridge, Research Fellow, University College London
Muscle, music and matches
Professor Michael Hanna, Senior Consultant Neurologist, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust
David and Fred’s excellent adventures in myositis
Professor Frederick Miller, Scientist Emeritus, National Institute of Environmental Health Sciences
A journey through obstetric rheumatology: From here to maternity
Professor Ian Giles, Professor of Rheumatology, Centre for Rheumatology Research, University College London
DOACs and APS: Back to the future
Professor Hannah Cohen, Consultant Haematologist, University College London Hospitals NHS Foundation Trust and Professor of Haematology, University College London
Tea and coffee break
Session 2
Chairs: Professor John Morrow, Human Microbiome Centre, King’s College London and Professor Pat Woo, Emeritus Professor, Paediatric Rheumatology, University College London
What have fats got to do with it?
Professor Liz Jury, Professor of Experimental Rheumatology, University College London
Making a song and dance about steroids
Professor Liz Lightstone, Professor of Renal Medicine, Imperial College London
B cell depletion therapy: Past, present and future
Dr Ed Vital, Associate Professor, School of Medicine, University of Leeds
Advancing knowledge in SLE: The game is about glory
Professor Ian Bruce, Professor of Rheumatology, University of Manchester
Clinical coronary artery disease in SLE: Newer concepts
Professor Murray Urowitz, Professor of Medicine, University of Toronto
Lupus: Tracking the butterfly and the wolf
Professor Caroline Gordon, Emeritus Professor of Rheumatology, University of Birmingham
Lunch break
Session 3
Chairs: Professor Peter Maddison, Professor Emeritus, School of Medical Sciences, Bangor University and Dr Michael Snaith, Retired Rheumatologist
David and the adolescent journey
Professor Lucy Wedderburn, Professor in Paediatric Rheumatology, Institute of Child Health, University College London
Antibodies, brain and colleagues
Professor Betty Diamond, Professor, Feinstein Institutes for Medical Research
Cognitive dysfunction in SLE: Single-center cohort presentation
Dr Raquel Faria, Consultant in Internal Medicine, Unidade de Imunologia Clínica, Portugal
To: David Isenberg From: The SLICCest view
Dr Rosalind Ramsey-Goldman, Gallagher Research Professor of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, USA
Tea and coffee break
Session 4
Chairs: Professor David Latchman, Vice-Chancellor, Birkbeck, University of London and Professor Marc Feldmann
Dr Isenberg I presume: A chance meeting in the jungle of lupus trials
Dr Joan Merrill, Professor of Medicine, Oklahoma Medical Research Foundation, University of Oklahoma
I think you are treating the wrong organs!
Professor Claudia Mauri, Professor of Immunology, Centre for Rheumatology and Bloomsbury Rheumatology Unit, University College London
Solar power: The sun and lupus
Professor Keith Elkon, Professor of Medicine and Immunology, University of Washington, USA
Can 'Haifa Road' be a substitute for Abbey Road?
Professor Alexandra Balbir-Gurman, Director, Rheumatology Institute, Ramjbam Health Care Campus
Advances in the treatment of rheumatoid arthritis - the next 50 years
Professor John Isaacs, Professor of Clinical Rheumatology, Newcastle University and Associate Medical Director, Research, Newcastle upon Tyne Hospitals NHS Foundation Trust
Lupus in Africa: A unicorn?
Dr Dzifa Dey, Senior Lecturer, University of Ghana Medical School and Consultant Rheumatologist, Korlebu Teaching Hospital, Accra, Ghana
Back to the future: When this baby hits autoantibodies you are going to see some serious (SLE)DAI
Professor Michael Ehrenstein, Professor of Experimental Rheumatology, University College London and Honorary Consultant Rheumatologist, University College London Hospitals NHS Foundation Trust
Closing remarks
Professor David Isenberg
Close of meeting
Drinks reception
Location
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom